Online Only Articles

CXCL13 levels are elevated in patients with Waldenström macroglobulinemia, and are predictive of major response to ibrutinib

St. Antonius Hospital, Nieuwegein, The Netherlands;Bing Center for WM, Dana Farber Cancer Insitute, Boston, MA, USA
Bing Center for WM, Dana Farber Cancer Insitute, Boston, MA, USA
Bing Center for WM, Dana Farber Cancer Insitute, Boston, MA, USA
Bing Center for WM, Dana Farber Cancer Insitute, Boston, MA, USA
Bing Center for WM, Dana Farber Cancer Insitute, Boston, MA, USA;Department of Medicine, Harvard Medical School, Boston, MA, USA
Bing Center for WM, Dana Farber Cancer Insitute, Boston, MA, USA
David Geffen School of Medicine, Los Angeles, CA, USA
Department of Pathology, Academic Medical Center, Amsterdam, the Netherlands
Department of Hematology, Academic Medical Center, Amsterdam, the Netherlands
Bing Center for WM, Dana Farber Cancer Insitute, Boston, MA, USA
Bing Center for WM, Dana Farber Cancer Insitute, Boston, MA, USA;Department of Medicine, Harvard Medical School, Boston, MA, USA
Bing Center for WM, Dana Farber Cancer Insitute, Boston, MA, USA;Department of Medicine, Harvard Medical School, Boston, MA, USA
Bing Center for WM, Dana Farber Cancer Insitute, Boston, MA, USA;Department of Medicine, Harvard Medical School, Boston, MA, USA
Vol. 102 No. 11 (2017): November, 2017 https://doi.org/10.3324/haematol.2017.172627